Immune cell activation and proliferation

Immune cell activation and proliferation is a fundamental biological process where quiescent immune cells, such as T and B lymphocytes, are stimulated to enter the cell cycle and perform effector functions (Janeway's Immunobiology, 2016). This process is typically triggered by the binding of antigens to specific receptors, such as the T-cell receptor (TCR) or B-cell receptor (BCR), and is further regulated by co-stimulatory molecules like CD28 (Nature Reviews Immunology, 2018). Once activated, these cells undergo rapid clonal expansion, a phase known as proliferation, which is essential for mounting a robust defense against pathogens and malignant cells (Cell, 2015). Dysregulation of this process is central to many pathologies; for example, excessive activation leads to autoimmune diseases and chronic inflammation, while suppressed activation allows for tumor evasion (Nature, 2011). Pharmacological intervention often targets specific nodes within this process to achieve therapeutic goals. Immunosuppressive drugs like cyclosporine and tacrolimus inhibit activation by blocking calcineurin signaling, thereby preventing organ transplant rejection (StatPearls, 2023). Conversely, cancer immunotherapies such as pembrolizumab and nivolumab aim to restore or enhance immune cell activation by blocking inhibitory checkpoints like PD-1 (NEJM, 2012). Because it represents a broad physiological outcome involving numerous molecular pathways, "Immune cell activation and proliferation" is classified as a biological process or mechanism of action rather than a single, discrete therapeutic target.

Other names

Immune activationLymphocyte proliferationLeukocyte activationT-cell activation and expansion

Modulation of signaling pathways (e.g., TCR/BCR signaling, calcineurin/NFAT pathway, mTOR pathway, and immune checkpoints) to regulate the activation state and expansion of immune cell populations (Nature Reviews Immunology, 2018).